Mycosis fungoides laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
Laboratory tests for splenic marginal zone lymphoma include:<ref name= seer.cancer> Cutaneous T cell lymphoma. Surveillance, Epidemiology, and End Results . http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52f7/ Accessed on January 19, 2016</ref> | Laboratory tests for splenic marginal zone lymphoma include:<ref name= seer.cancer> Cutaneous T cell lymphoma. Surveillance, Epidemiology, and End Results . http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52f7/ Accessed on January 19, 2016</ref> | ||
* [[Complete blood count]] (CBC) | * [[Complete blood count]] (CBC) | ||
* Peripheral blood | |||
:* Atypical T-cells ("Sezary cells") | |||
* Blood chemistry studies | * Blood chemistry studies | ||
* [[Flow cytometry]] | * [[Flow cytometry]] | ||
Revision as of 14:28, 20 January 2016
|
Cutaneous T cell lymphoma Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Laboratory tests for cutaneous T cell lymphoma include complete blood count (CBC), blood chemistry studies, flow cytometry, immunohistochemistry, and immunophenotyping.[1]
Laboratory tests
Laboratory tests for splenic marginal zone lymphoma include:[1]
- Complete blood count (CBC)
- Peripheral blood
- Atypical T-cells ("Sezary cells")
- Blood chemistry studies
- Flow cytometry
- Immunohistochemistry
- Immunophenotyping: Beta F1+, CD2-/+, CD3+, CD3- (CD4-positive variant), CD4+ (CD4-positive variant), CD4-, CD5-, CD7+/-, CD8+, CD8- (CD4-positive variant), Granzyme B+, Perforin+
References
- ↑ 1.0 1.1 Cutaneous T cell lymphoma. Surveillance, Epidemiology, and End Results . http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52f7/ Accessed on January 19, 2016